
Breast Cancer Surgical De-escalation: Evidence and Boundaries
Less extensive surgery is a research direction, not a universal treatment rule. This evidence brief maps what recent reviews and cohort data can—and cannot—establish.
Read the briefOriginal, source-linked evidence briefs for professional scientific exchange.
Source-linked briefs summarize study design, findings, and limitations. They are editorial education content, not clinical review or individual medical advice.

Less extensive surgery is a research direction, not a universal treatment rule. This evidence brief maps what recent reviews and cohort data can—and cannot—establish.
Read the brief
Robotic nipple-sparing mastectomy has a growing comparative literature. The current evidence describes perioperative trade-offs more clearly than long-term oncologic outcomes.
Read the brief
Recent studies examine robotic thoracic surgery after neoadjuvant therapy and a single-port platform. Their designs support cautious interpretation, not a universal technique preference.
Read the brief
A recent study evaluates dynamic ctDNA measurement in advanced lung squamous cell carcinoma. It reports prognostic associations, while important validation and clinical-utility questions remain.
Read the brief
Hormonal therapies have distinct roles in selected endometrial cancer settings and in survivorship symptom care. These are separate decisions, each requiring attention to tumor context and evidence limits.
Read the brief
AI tools are being studied across the radiotherapy workflow. Reviews and working-group assessments describe potential roles and implementation challenges, while clinical benefit must be evaluated tool by tool.
Read the brief